BioInnovation Institute (BII) joins the global CARB-X network to accelerate start-ups in drug-resistant infections
Medicon Valley Alliance
February 26, 2019
An estimated 700,000 people die each year worldwide from bacterial infections. New antibiotics, rapid diagnostics, vaccines and other products are urgently needed to treat bacteria that are increasingly resistant to existing antibiotics. This is the challenge adressed by the Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator (CARB-X), which is now expanding its Global Accelerator Network to include among others BII.
